Diagnosis of Pompe disease: muscle biopsy vs blood-based assays

J Vissing, Z Lukacs, V Straub - JAMA neurology, 2013 - jamanetwork.com
The diagnosis of Pompe disease (acid maltase deficiency, glycogen storage disease type II)
in children and adults can be challenging because of the heterogeneous clinical …

Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial

L Klinge, V Straub, U Neudorf, J Schaper… - Neuromuscular …, 2005 - Elsevier
Pompe disease is an autosomal recessive muscle-wasting disorder caused by the
deficiency of the lysosomal enzyme acid alpha-glucosidase. Due to virtual absence of acid …

[HTML][HTML] Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker

SP Young, H Zhang, D Corzo, BL Thurberg, D Bali… - Genetics in …, 2009 - Elsevier
Purpose To investigate the correlation of the urinary glucose tetrasaccharide, Glcα1-6Glcα1-
4Glcα1-4Glc,(Glc 4) with skeletal muscle glycogen content and the long-term clinical …

Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients

DL Bernstein, MG Bialer, L Mehta… - Molecular Genetics and …, 2010 - Elsevier
Pompe disease is a lysosomal storage disease due to deficient acid α-glucosidase (GAA)
activity. Infants with the classic infantile-onset subtype present with severe hypotonia and …

Pompe disease: design, methodology, and early findings from the Pompe Registry

BJ Byrne, PS Kishnani, LE Case, L Merlini… - Molecular genetics and …, 2011 - Elsevier
Pompe disease is an autosomal recessive, progressive, debilitating, and often fatal
neuromuscular disorder caused by deficiency of lysosomal acid α-glucosidase (GAA). It is …

Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study

L Klinge, V Straub, U Neudorf, T Voit - Neuropediatrics, 2005 - thieme-connect.com
Infantile Pompe disease (IPD) is a fatal, autosomal recessive muscle-wasting disorder. Due
to a deficiency of the lysosomal enzyme acid alpha-glucosidase patients develop a …

Pompe disease: a clinical, diagnostic, and therapeutic overview

D Stevens, S Milani-Nejad, T Mozaffar - Current treatment options in …, 2022 - Springer
Abstract Purpose of Review This review summarizes the clinical presentation and provides
an update on the current strategies for diagnosis of Pompe disease. We will review the …

Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease

CI Van Capelle, LPF Winkel, MLC Hagemans… - Neuromuscular …, 2008 - Elsevier
Pompe disease (type 2 glycogenosis, acid maltase deficiency) is a disorder affecting
skeletal and cardiac muscle, caused by deficiency of acid α-glucosidase. In 2006 enzyme …

Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory

JL Goldstein, SP Young, M Changela… - Muscle & …, 2009 - Wiley Online Library
Pompe disease (acid maltase deficiency; glycogen storage disease type II) is caused by
deficiency of the lysosomal enzyme acid alpha‐glucosidase (GAA). Our clinical laboratory …

Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome

RR Howell, B Byrne, BT Darras, P Kishnani… - Genetics in …, 2006 - nature.com
Pompe disease, a disorder caused by a deficiency in the lysosomal enzyme acid alpha
glucosidase, is frequently overlooked as a cause of floppy baby syndrome. The accurate …